高雄醫學大學醫學檢驗生物技術學系博士

早稻田大學科學與工程研究所兼任研究員

義守大學醫學檢驗技術學系助理教授

嘉登生技有限公司執行長

高雄醫學大學液態生物檢體暨世代研究中心助理研究員

高雄醫學大學液態生物檢體暨世代研究中心博士後研究員

馬偕醫學院醫學檢驗暨再生醫學學系助理教授

馬偕醫學院研究發展處產學事業組組長

檢驗醫學臨床微生物、分子流行病學細菌抗藥性機轉、分子生物學新興抗菌製劑藥物、醫材、法規等材料科學

臨床微生物學、分子生物學、臨床生物化學、材料科學

1. Jung-Chang Kung, Hui-Ci Yang, Yang TY*, Chi-Jen Shih.  Assessment of Silver-Copper Co-Loaded Mesoporous Bioactive Glass as an Advanced Pulp-Capping Material.. Journal of dentistry. Vol.153:105549-105549. Feb. 2025. (SCI/SCIE)
2. Yu-Cin Deng, Chi-Jen Shih, Shang-Yi Lin, Liang-Chun Wang, Yang TY*, Sung-Pin Tseng.  Synergistic effect between taurine-induced silver ion and itraconazole against azole-resistant Candida species and Candida auris. Journal of Microbiology Immunology and Infection. Vol.In Press:In Press-In Press. Jan. 2025. (SCI/SCIE)
3. Wong KW, Li YJ, Yang HC, Chien CS, Kao LT, Lin TS, Yang TY*, Shih CJ.  Antimicrobial properties of bimetallic-containing mesoporous bioglass against Enterococcus faecalis.. Journal of Dental Sciences. Vol.20-No.1:510-521. Jan. 2025. (SCI/SCIE)
4. Ho CH, Yang TY, Tseng SP, Su PY.  Antimicrobial efficacy and amino acid substitutions associated with susceptibility to the tellurium compound AS101 against Haemophilus influenzae and Haemophilus parainfluenzae.. INTERNATIONAL MICROBIOLOGY. Vol.Online:Online-Online. Jul. 2024. (SCI/SCIE)
5. Huang PW, Liou CY, Lee YC, Wei TY, Ho HC, Yang TY*, Wang LC.  The evaluation of teleost-derived antimicrobial peptides against Neisseria gonorrhoeae.. Cureus Journal of Medical Science. Vol.16-No.3:e57168. Mar. 2024. (SCI/SCIE)
6. Chen RZ, Lu PL, Yang TY, Lin SY, Tang HJ, Chang FY, Yang YS, Chiang TT, Wang FD, Wu TS, Shie SS, Ho MW, Liu JW, Shi ZY, Chou CH, Chuang YC.  Efficacy of cefoperazone/sulbactam for ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and the factors associated with poor outcomes.. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. Vol.79-No.3:648-655. Feb. 2024. (SCI/SCIE)
7. Kang JC, Yang TY, Hung CC, Shih CJ.  silica-based silver nanocomposite 80S/Ag as Aggregatibacter actinomycetemcomitans inhibitor and its in vitro bioactivity.. Journal of Dental Sciences. Vol.19-No.1:568-579. Jan. 2024. (SCI/SCIE)
8. Yang TY, Chern GI, Wang WH, Shih CJ.  Synthesis, Characterization, and Bioactivity of Mesoporous Bioactive Glass Codoped with Zinc and Silver. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Vol.24-No.18:13679-13697. Sep. 2023. (SCI/SCIE)
9. Yang TY, Hung WC, Tsai TH, Lu PL, Wang SF, Wang LC, Lin YT.  Potentials of organic tellurium-containing compound AS101 to overcome carbapenemase-producing Escherichia coli.. Journal of Microbiology Immunology and Infection. Vol.56-No.5:1016-1025. Jul. 2023. (SCI/SCIE)
10. Lin HH, Li JW, Yang TY, Lee CY, Jain SH, Lin SY,  Lu PL.  Emergence of a predominant sequence type ST7363 and the increasing trend of resistance to cefixime and ceftriaxone in Neisseria gonorrhoeae in Southern Taiwan, 2019–2021.. Journal of Microbiology Immunology and Infection. Vol.56-No.4:833-841. Mar. 2023. (SCI/SCIE)
11. Yang TY, Tseng SP, Ho HC,  Chen LH, Hsueh PR, Lu PL, Lin CH, Wang LC.  In vitro evaluation of tellurium-based AS101 compound against Neisseria gonorrhoeae infectivity.. Microbiology Spectrum. Vol.11-No.2:e0149622. Mar. 2023. (SCI/SCIE)
12. Huang HY, Chang YT,  Lu PL, Yang TY, Wang YL, Chen TC, Wu JH, Lin SY.  Correlation of Vitek 2 and Agar dilution for levofloxacin susceptibility testing and clinical outcomes of Enterobacterales bacteremia with 2019 CLSI breakpoints.. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. Vol.104-No.4:115799-115799. Aug. 2022. (SCI/SCIE)
13. Huang YC, Lin TY, Huang SC, Yang TY*,  Shih CJ.  Copper-enhanced silver releasing from bimetal-containing bioactive glass (AgCu/80S) elicits antibacterial efficacy against drug-resistant Staphylococcus aureus.. Journal of Non-Crystalline Solids. Vol.548:121509-121509. May. 2022. (SCI/SCIE)
14. Yang TY, Hsieh YJ, Kao LT, Liu GH,  Lian SH, Wang LC, Lin IL, Wang HY, Tseng SP, Lu PL.  Activities of imipenem-relebactam combination against carbapenem-nonsusceptible Enterobacteriaceae in Taiwan.. Journal of Microbiology Immunology and Infection. Vol.55-No.1:86-94. Feb. 2022. (SCI/SCIE)
15. Sung CL, Hung WC, Lu PL, Lin L, Wang LC, Yang TY*, Tseng SP.  Synergistic combination of AS101 and azidothymidine against clinical isolates of carbapenem-resistant Klebsiella pneumoniae.. Pathogens. Vol.10-No.12:1552-1552. Nov. 2021. (SCI/SCIE)
16. Huang YC, Yang TY, Chen BX, Kung JC, Shih CJ.  Evaluation of Antibacterial Effects of Matrix-Induced Silver Ions against Antibiotic-Resistant ESKAPE Pathogens.. Pharmaceuticals. Vol.14-No.11:1094-1094. Oct. 2021. (SCI/SCIE)
17. Yang TY, Kao HY, Lu PL, Chen PY, Wang SC,  Wang LC, Hsieh YJ, Tseng SP.  Evaluation of the Organotellurium Compound AS101 for Treating Colistin- and Carbapenem-Resistant Klebsiella pneumoniae.. Pharmaceuticals. Vol.14-No.8:795-795. Aug. 2021. (SCI/SCIE)
18. Yang TY, Tseng SP, Dlamini HN, Lu PL, Lin L, Wang LC, Hung WC.  In Vitro and In Vivo Activity of AS101 against Carbapenem-Resistant Acinetobacter baumannii.. Pharmaceuticals. Vol.14-No.8:823-823. Aug. 2021. (SCI/SCIE)
19. Yang TY,  Hsieh YJ,  Lu PL, Lin L, Wang LC, Wang HY, Tsai TH, Shih CJ, Tseng SP.  In vitro and in vivo assessments of inspired Ag/80S bioactive nanocomposites against carbapenem-resistant Klebsiella pneumoniae.. Materials Science & Engineering C-Materials for Biological Applications. Vol.125:112093-112093. Jun. 2021. (SCI/SCIE)
20. Yang TY,  Hsieh YJ, Kao LT, Liu GH, Lian SH, Wang LC,  Lin IL, Lin YT, Wang SF, Tseng SP, Lu PL.  In vitro and in vivo evaluations of β-lactam/β-lactamase mono- and combined therapies against carbapenem-nonsusceptible Enterobacteriaceae in Taiwan.. Microorganisms. Vol.8-No.12:1981-1981. Dec. 2020. (SCI/SCIE)
21. Chang YT, Yang TY, Lu PL, Lin SY, Wang LC, Wang SF, Hsieh YJ, Tseng SP.  Combination of colistin and azidothymidine demonstrates synergistic activity against colistin-resistant, carbapenem-resistant Klebsiella pneumoniae.. Microorganisms. Vol.8-No.12:1964-1964. Nov. 2020. (SCI/SCIE)
22. Yang TY, Wang SF, Lin JE, Griffith BTS, Lian SH, Hong ZD, Lin L, Lu PL.  Contributions of insertion sequences conferring colistin resistance in Klebsiella pneumoniae.. International Journal of Antimicrobial Agents. Vol.55-No.3:105894-105894. Mar. 2020. (SCI/SCIE)
23. Yang TY, Lu PL, Tseng SP.  Update on fosfomycin-modified genes in Enterobacteriaceae.. Journal of Microbiology Immunology and Infection. Vol.52-No.1:9-21. Feb. 2019. (SCI/SCIE)
24. Lin L, Wang SF, Yang TY, Hung WC, Chan MY, Tseng SP.  Antimicrobial resistance and genetic diversity in ceftazidime non-susceptible bacterial pathogens from ready-to-eat street foods in three Taiwanese cities. Scientific Reports. Vol.7:15515-15523. Nov. 2017. (SCI/SCIE)
25. Tseng SP, Wang SF, Ma L, Wang TY, Yang TY, Siu LK, Chuang YC, Lee PS, Wang JT, Wu TL, Lin JC, Lu PL.  The plasmid-mediated fosfomycin resistance determinants and synergy of fosfomycin and meropenem in carbapenem-resistant Klebsiella pneumoniae isolates in Taiwan.. Journal of Microbiology Immunology and Infection. Vol.50-No.5:653-661. Oct. 2017. (SCI/SCIE)
26. Yang TY, Lin L, Hung WC, Tseng SP.  mecA-related structure in methicillin-resistant coagulase-negative staphylococci from street food in Taiwan. Scientific Reports. Vol.7:42205-42213. Feb. 2017. (SCI/SCIE)
27. Lu PL, Hsieh YJ, Lin JE, Huang JW, Yang TY,  Lin L, Tseng SP.  Characterization of fosfomycin resistance mechanisms and molecular epidemiology in extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates.. International Journal of Antimicrobial Agents. Vol.48-No.5:564-568. Nov. 2016. (SCI/SCIE)

zegmayang@mmc.edu.tw